Minerva Neurosciences Stock Technical Analysis
| NERV Stock | USD 4.80 0.58 13.74% |
As of the 8th of February, Minerva Neurosciences secures the Risk Adjusted Performance of 0.081, downside deviation of 5.53, and Mean Deviation of 4.09. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Minerva Neurosciences, as well as the relationship between them. Please verify Minerva Neurosciences standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Minerva Neurosciences is priced some-what accurately, providing market reflects its recent price of 4.8 per share. Given that Minerva Neurosciences has jensen alpha of 0.3633, we recommend you to check Minerva Neurosciences's last-minute market performance to make sure the company can sustain itself at a future point.
Minerva Neurosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Minerva, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MinervaMinerva Neurosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Minerva Neurosciences Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 4.0 | Hold | 1 | Odds |
Most Minerva analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Minerva stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Minerva Neurosciences, talking to its executives and customers, or listening to Minerva conference calls.
What growth prospects exist in Biotechnology sector? Can Minerva capture new markets? Factors like these will boost the valuation of Minerva Neurosciences. Anticipated expansion of Minerva directly elevates investor willingness to pay premium valuations. Valuation analysis balances hard financial data with qualitative growth assessments. While each Minerva Neurosciences valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Understanding Minerva Neurosciences requires distinguishing between market price and book value, where the latter reflects Minerva's accounting equity. The concept of intrinsic value - what Minerva Neurosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Market sentiment, economic cycles, and investor behavior can push Minerva Neurosciences' price substantially above or below its fundamental value.
It's important to distinguish between Minerva Neurosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Minerva Neurosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Minerva Neurosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Minerva Neurosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Minerva Neurosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Minerva Neurosciences.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Minerva Neurosciences on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Minerva Neurosciences or generate 0.0% return on investment in Minerva Neurosciences over 90 days. Minerva Neurosciences is related to or competes with Klotho Neurosciences, Neurosense Therapeutics, Exicure, Neuraxis, Collplant Biotechnologies, TAO Synergies, and Rallybio Corp. Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercializatio... More
Minerva Neurosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Minerva Neurosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Minerva Neurosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.53 | |||
| Information Ratio | 0.0736 | |||
| Maximum Drawdown | 25.06 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 10.58 |
Minerva Neurosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Minerva Neurosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Minerva Neurosciences' standard deviation. In reality, there are many statistical measures that can use Minerva Neurosciences historical prices to predict the future Minerva Neurosciences' volatility.| Risk Adjusted Performance | 0.081 | |||
| Jensen Alpha | 0.3633 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.0733 | |||
| Treynor Ratio | 0.3175 |
Minerva Neurosciences February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.081 | |||
| Market Risk Adjusted Performance | 0.3275 | |||
| Mean Deviation | 4.09 | |||
| Semi Deviation | 5.03 | |||
| Downside Deviation | 5.53 | |||
| Coefficient Of Variation | 1112.12 | |||
| Standard Deviation | 5.51 | |||
| Variance | 30.31 | |||
| Information Ratio | 0.0736 | |||
| Jensen Alpha | 0.3633 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.0733 | |||
| Treynor Ratio | 0.3175 | |||
| Maximum Drawdown | 25.06 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 10.58 | |||
| Downside Variance | 30.58 | |||
| Semi Variance | 25.3 | |||
| Expected Short fall | (4.23) | |||
| Skewness | 0.1472 | |||
| Kurtosis | 0.8318 |
Minerva Neurosciences Backtested Returns
Minerva Neurosciences appears to be risky, given 3 months investment horizon. Minerva Neurosciences has Sharpe Ratio of 0.0941, which conveys that the firm had a 0.0941 % return per unit of risk over the last 3 months. By analyzing Minerva Neurosciences' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please exercise Minerva Neurosciences' Mean Deviation of 4.09, risk adjusted performance of 0.081, and Downside Deviation of 5.53 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Minerva Neurosciences holds a performance score of 7. The company secures a Beta (Market Risk) of 1.53, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Minerva Neurosciences will likely underperform. Please check Minerva Neurosciences' value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether Minerva Neurosciences' current price movements will revert.
Auto-correlation | 0.27 |
Poor predictability
Minerva Neurosciences has poor predictability. Overlapping area represents the amount of predictability between Minerva Neurosciences time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Minerva Neurosciences price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Minerva Neurosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Minerva Neurosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Minerva Neurosciences Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Minerva Neurosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Minerva Neurosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Minerva Neurosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Minerva Neurosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Minerva Neurosciences price pattern first instead of the macroeconomic environment surrounding Minerva Neurosciences. By analyzing Minerva Neurosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Minerva Neurosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Minerva Neurosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Interest Debt Per Share | 0.69 | 1.17 | Revenue Per Share | 7.26 | 6.46 |
Minerva Neurosciences February 8, 2026 Technical Indicators
Most technical analysis of Minerva help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Minerva from various momentum indicators to cycle indicators. When you analyze Minerva charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.081 | |||
| Market Risk Adjusted Performance | 0.3275 | |||
| Mean Deviation | 4.09 | |||
| Semi Deviation | 5.03 | |||
| Downside Deviation | 5.53 | |||
| Coefficient Of Variation | 1112.12 | |||
| Standard Deviation | 5.51 | |||
| Variance | 30.31 | |||
| Information Ratio | 0.0736 | |||
| Jensen Alpha | 0.3633 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.0733 | |||
| Treynor Ratio | 0.3175 | |||
| Maximum Drawdown | 25.06 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 10.58 | |||
| Downside Variance | 30.58 | |||
| Semi Variance | 25.3 | |||
| Expected Short fall | (4.23) | |||
| Skewness | 0.1472 | |||
| Kurtosis | 0.8318 |
Minerva Neurosciences February 8, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Minerva stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.16 | ||
| Daily Balance Of Power | 0.74 | ||
| Rate Of Daily Change | 1.14 | ||
| Day Median Price | 4.52 | ||
| Day Typical Price | 4.61 | ||
| Price Action Indicator | 0.57 | ||
| Market Facilitation Index | 0.78 |
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.